[February 20, 2013]

Research and Markets: China Healthcare Company Analysis - Fosun Pharmaceutical

Research and Markets (http://www.researchandmarkets.com/research/wzzrhl/china_healthcare) has announced the addition of the "China Healthcare Company Analysis - Fosun Pharmaceutical" company profile to their offering.

Fosun Pharmaceutical is one of the pharmaceutical giants in China covering drug manufacturing, distribution and retails, diagnostics and even medical devices. It had achieved revenues of RMB 6.5 billion in 2011. This report will provide you with more insightful information of Fosun Pharmaceutical, covering its history, business, revenues and costs, people, shaeholders and subsidiaries, recent activities and future development.

Reasons of Buying

• More original information based on the Chinese language
• Detailed analysis of the company
• Constantly updated
• Strong after sale support to clients who have access to Shanghai-based experienced analysts for further questions

Who should Buy

• Decision makers who are looking for M&A opportunities in China
• Decision makers who are responsible for market intelligence in China
• Decision makers who are responsible for business development in China
• Investors
• Consultants

Key Topics Covered:

1. Fosun Pharmaceutical Overview

2. Finance

2.1 Balance Sheet

2.2 Revenues

2.3 Costs

2.4 Profits

3. People

3.1 Board of Director

3.2 Management Team

3.3 Employee

4. Operation

4.1 Risk Analysis

4.2 Recent Activities

4.3 Future Development

5. Directory of Fosun Pharmaceutical's Related Companies

For more information visit http://www.researchandmarkets.com/research/wzzrhl/china_healthcare

[ Back To Technology News's Homepage ]